Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.28-$1.66 |
Market Cap | $530.5M |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $70.8M |
Revenue Growth (YoY) | 710.4% |
Gross Profit (12 Mos) | -$4.9M |
Diluted EPS | -$0.19 |
News
See moreYahoo Finance • 10 days ago
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
Yahoo Finance • 12 days ago
Lexicon Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides R&D Updates
Yahoo Finance • 19 days ago
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
Yahoo Finance • last month
Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People with Chronic Pain
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
